SCHEMBL25872303

SCHEMBL25872303

O=C(CNS(=O)(=O)C1CCCCCCC1)C1CCCCCCCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
TBXA2R P21731 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
EPHX1 P07099 1/20 0.35
EPHX2 P34913 2/20 0.35
TSHR P16473 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MMP1 P03956 1/20 0.34
MMP7 P09237 1/20 0.34
MMP12 P39900 1/20 0.34
ECE1 P42892 1/20 0.34
MMP13 P45452 1/20 0.34
TBXAS1 P24557 1/20 0.32
ALDH1A1 P00352 1/20 0.31
PGAM1 P18669 1/20 0.31
GAA P10253 1/20 0.31
NAAA Q02083 1/20 0.31
PRMT3 O60678 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25871136 1.00 CES2 (0.37) CES2CES1TBXA2RHDAC8HDAC6
SCHEMBL8788461 0.81 TBXAS1 (0.38) TBXA2RHDAC6EPHX2L3MBTL1MMP1
SCHEMBL8788740 0.81 TBXAS1 (0.38) TBXA2RHDAC6EPHX2L3MBTL1MMP1
SCHEMBL8789191 0.81 TBXAS1 (0.38) TBXA2RHDAC6EPHX2L3MBTL1MMP1
SCHEMBL13783852 0.79 MMP1 (0.44) TBXA2RHDAC8HDAC6MMP1MMP7
SCHEMBL11308021 0.76 EPHX2 (0.47) TBXA2REPHX2MMP1MMP7MMP12
SCHEMBL22169623 0.74 TBXAS1 (0.33) CES2CES1TBXA2RHDAC8HDAC6
SCHEMBL19540775 0.73 CES2 (0.48) CES2CES1HDAC8HDAC6EPHX1
SCHEMBL22169725 0.71 HDAC8 (0.50) CES2CES1HDAC8HDAC6EPHX1
SCHEMBL8224007 0.71 CA1 (0.39) CES2CES1TBXA2RHDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174470-A1 COMPOUND AS A UBR BOX DOMAIN LIGAND AUTOTAC INC. (KR) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174470-A1 COMPOUND AS A UBR BOX DOMAIN LIGAND UBR4, UBQLN2, UBTF CES2 4084/4885CES1 3160/4885TBXA2R 2793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.